Environmental, Social and Governance Progress Report

Overview

The report describes Teva's 2022 progress in reducing Scope 1 and 2 GHG emissions by 24.1% and Scope 3 emissions by 12%, with targets validated by the Science Based Targets initiative. It highlights five access-to-medicines programs and 533.7M donated medicine units worth $699.6M. Teva reported a global workforce of 36,826 employees, including contractors, and the ESG Progress Report received limited independent assurance from DNV.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services